| Parameter | Score |
|---|---|
| 1. Scale | A |
| 2. Study Population | A |
| 3. Samples | A |
| 4. Measurand | A |
| 5. Pre-Analytical | A |
| 6. Replicate Analysis | A |
| 7. Steady State | B |
| 8. Outlier Analysis | C |
| 9. Normality | A |
| 10. Variance Homogeneity | C |
| 11. ANOVA | A |
| 12. CI | A |
| 13. No of Results | B |
| 14. Concentrations | B |
| 15. Total Score | C8,10 |
| Comment |
| Parameter | Score |
|---|---|
| Matrix | Serum |
| Measurand | Carcinoembryonic antigen (CEA) |
| Unit | ng / mL |
| Overall Analytical Principle Method | Immunoassay; Not specified |
| Number of Subjects | 20 |
| Number of Subjects included in BV estimation | 20 |
| Ethinicity | Asian |
| Age Mean / Median | 26.0 |
| Age Min | 21.0 |
| Age Max | 38.0 |
| Age SD | |
| Number of Males | 11 |
| Number of Females | 9 |
| State of Well Being |
Healthy (excl pregnant)
|
| Diseases | |
| Study Duration Length | 5 |
| Study Duration Units | Day |
| Sampling Intervals, e.g. X sample(s) per Interval Unit | |
| Interval Units | Hour |
| Sampling Times | Start Time:
08:00
End Time: 16:00 |
| Number of Samples | 7 |
| Average Number of Samples Used for BV Estimation | 7.0 |
| Average Number of Replicates | 2.0 |
| Estimates of CVi | 10.95 |
| Calculated Confidence Intervals of CVi | Lower: 9.70, Upper: 12.56 |
| Estimates of CVg | 46.74 |
| Calculated Confidence Intervals of CVg | Lower: 35.66, Upper: 67.63 |
| Analytical CV | 2.15 |
| Calculated Confidence Intervals of Analytical CV | Lower: 1.92, Upper: 2.44 |
| Measurand Mean | 1.67 |
| Measurand Min | 0.61 |
| Measurand Max | 2.73 |
| Measurand SD |